Researchers find that molecular traces obtained from people's phones can give a glimpse into their lifestyle, the Huffington Post reports.
C4BPA could prove useful as a diagnostic biomarker for early stage pancreatic cancer and to help differentiate the disease from other cancers.
Scientists from Kyoto University designed reagents that labeled proteins only in the presence of zinc ions for later analysis by mass spec.
The researchers said the bones likely belonged to individuals who were among the latest Neanderthals in Western Europe.
US Army scientists have developed a way to more precisely determine the amount of antigen needed as they develop an Ebola virus-like particle vaccine.
The communication concerns a software defect that can cause several of the company's mass spectrometry instruments to incorrectly assign results to samples.
Researchers also uncovered key pathways and alterations linked to differences in survival.
The WUSTL-developed method detects a bile acid that is found at increased levels in Niemann-Pick patients, and is ready for pilot testing, its developers said.
The group hopes to find biomarkers as a first step toward identifying or developing targeted therapeutics to avoid serious and life threatening outcomes of early lung disease in these newborns.
Critical Path will license Dow AgroScience's Plextein technology for multiplex detection of plant proteins using mass spectroscopy and provide it as a service.
In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.
Technology Review points out that a new US presidential science advisor hasn't been selected.
Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.
President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.